HIF/HIF Prolyl-Hydroxylase

HIFs (Hypoxia-inducible factors) are transcription factors that respond to changes in available oxygen in the cellular environment, to be specific, to decreases in oxygen, or hypoxia. The HIF signaling cascade mediates the effects of hypoxia, the state of low oxygen concentration, on the cell. Hypoxia often keeps cells from differentiating. However, hypoxia promotes the formation of blood vessels, and is important for the formation of a vascular system in embryos, and cancer tumors. The hypoxia in wounds also promotes the migration of keratinocytes and the restoration of the epithelium. In general, HIFs are vital to development. In mammals, deletion of the HIF-1 genes results in perinatal death. HIF-1 has been shown to be vital to chondrocyte survival, allowing the cells to adapt to low-oxygen conditions within the growth plates of bones. HIF plays a central role in the regulation of human metabolism. Recently, several drugs that act as selective HIF prolyl-hydroxylase inhibitors have been developed.

HIF/HIF Prolyl-Hydroxylase亚型特异性产品:HIF/HIF Prolyl-Hydroxylase Isoform Comparison
共 9种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
FAM-DEALA-Hyp-YIPMDDDFQLRSF-NH2

FAM-DEALA-Hyp-YIPMDDDFQLRSF-NH2 是一种 5-FAM 标记的 HIF-1α 肽,作为 VHL 的底物,可与 VHL 蛋白结合(KD 为 3 nM),其 Ex/Em (λ) = 485/520 nm。

Agonist
FAM-DEALA-Hyp-YIPMDDDFQLRSF-NH2
HIF-2α agonist 2

HIF-2α agonist 2 (compound 10) 是一种 HIF-2α 激动剂,在 20 μM 剂量下 EC50 值为 1.68 μM,对 786-O-HRE-Luc 细胞无细胞毒性,可用于氧代谢研究。

2750141-15-0
Agonist
99.59%
HIF-2α agonist 2
HIF-2α agonist 3

HIF-2α agonist 3(Compound 14d)是一种具有口服活性的 HIF-2α 激动剂,EC50 值为 1.78 μM,可用于肾性贫血的研究。

Agonist
HIF-2α agonist 3
HIF1 agonist-1

HIF1 agonist-1(化合物 F4)是一种有效的 HIF1 激动剂,EC50 为 0.9 μM,可用于抗癌研究。

333314-79-7
Agonist
99.11%
HIF1 agonist-1
M1001

M1001 是一种较弱的低氧诱导因子-2α (HIF-2α) 激动剂,可与 HIF-2α PAS-B 结构域结合(Kd 值为 667 nM),可用于慢性肾脏病的研究。

874590-32-6
Agonist
99.51%
M1001
M1002

M1002 是一种缺氧诱导因子-2 (HIF-2) 激动剂,可增强 HIF-2 靶基因的表达,并与脯氨酰羟化酶结构域 (PHD) 抑制剂发挥协同作用。

823830-85-9
Agonist
99.69%
M1002
ZG-2033

ZG-2033 (Compound 26) 是一种具有口服活性的 HIF-2α 激动剂,在荧光素酶报告基因测定中显示出纳摩尔活性 (EC50 = 490 nM),具有减轻贫血的作用,并与 AKB-6548 (MS-C50385) 在贫血中具有协同作用,可用于肾性贫血的研究。

2685739-28-8
Agonist
ZG-2033
ZG-2686

ZG-2686 是一种强效的选择性 HIF-2α 激动剂(EC50 为 0.25 µM),对 PHD2 具有选择性,其通过与 HIF-2α 的特定内部空腔结合并经结构水分子形成氢键,从而稳定 HIF-2α/β 异二聚体并增强其转录活性,且与 Vadadustat (MS-C50385) 具有协同作用,可在体外和体内上调 HIF-2α 依赖的 EPO 基因表达,可用于肾性贫血的研究。

1795110-22-3
Agonist
ZG-2686
Beta-Sitosterol (purity>98%)
β-谷甾醇 (purity>98%); β-Sitosterol (purity>98%); 22,23-Dihydrostigmasterol (purity>98%)

Beta-Sitosterol(纯度>98%)具有口服活性,表现出抗炎、抗癌、抗氧化、抗菌、抗糖尿病、抗氧化酶及镇痛等多种活性,通过降低ROS、TNF-α、IL-1β、NF-κB p65水平并恢复HIF-1α/mTOR信号通路活力来抑制牛乳腺上皮细胞炎症和脂肪生成障碍,通过ROS介导的线粒体失调和p53激活诱导癌细胞凋亡(apoptosis),并在癌细胞中通过激活caspase-3、caspase-8、caspase-9,介导PARP失活、MMP缺失、Bcl-2-Bax比例改变及细胞色素c释放发挥抗癌作用,同时可调节巨噬细胞极化、减轻小鼠类风湿性炎症,并在多种癌症小鼠模型中抑制肿瘤生长,可用于关节炎、肺癌、乳腺癌等多种癌症及糖尿病等的研究。

83-46-5
Agonist
99.74%
β-谷甾醇 (purity>98%);谷固醇 (purity>98%);谷甾醇 (purity>98%);麦固醇 (purity>98%)

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础